Wall Street equity research analysts tracking electroCore, Inc. (NASDAQ: ECOR) maintain an average 12-month consensus price target of approximately $18.96 to $19.57, with individual analyst forecasts ranging from a low estimate of $12.00 up to a high estimate of $26.00, reflecting strong upside expectations driven by expanding medical device sales.